Literature DB >> 6247316

Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.

R Wise, J M Andrews, K A Bedford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6247316     DOI： 10.1093/jac/6.2.197

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  32 in total

1.  Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.

Authors:  R A Blum; R K Kohli; N J Harrison; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.

Authors:  R J Fass; W W Gregory; R F D'Amato; J M Matsen; D N Wright; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.

Authors:  E T Houang; N Colley; M Chapman
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

4.  A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease.

Authors:  J Gunning
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections.

Authors:  J Gisby; A S Beale
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

6.  In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.

Authors:  R N Jones
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 7.  Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  H A Friedel; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

8.  Antibacterial activity and kill kinetics of ampicillin/sulbactam (CP-45899) combinations against Escherichia coli and Klebsiella aerogenes.

Authors:  J E Fuglesang; T Bergan
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

Review 9.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

10.  Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery.

Authors:  C Martin; M N Mallet; B Sastre; X Viviand; A Martin; P De Micco; F Gouin
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.